Bernard Lim

Chief Operating Officer @ Cardiol Therapeutics Inc.

About

Proven track record of over twenty five years as a senior executive leading life sciences companies spanning biotechnology, diagnostics, medical devices, and high-technology companies in North America and Europe. Bernard leads senior management teams through a sustained focus on strategy, rapid scale up and increasing talent depth to expand markets served. Currently as COO of Cardiol Therapeutics, a clinical-stage biotechnology company developing anti-inflammatory therapies for the treatment of cardiovascular disease where he leads strategic operations. Founder and CEO of a highly successful drug delivery company that he led from R&D through to commercialization, an exponential growth rate and its eventual acquisition by Eli Lily. As Chair of the Board of Altus Assessments, he guided its spinout from the university and its subsequent rapid growth to become market leader in US and Canada. As Chair of the Board and CEO of AndersDx (UK), he led its turnaround and subsequent growth to market leader. He is currently Chair of the Board of Front Line Medical Technologies (Canada), a vascular trauma company and board director of Aventamed (Ireland). Bernard was Senior Vice President, Operations for Vasogen (Canada), as well as head of UK operations for a technology multinational where he scaled its operations exponentially and delivered multifold improvements in quality and financial performance. He was CEO of a Glaucoma, Alzheimer’s and an In-Vitro Diagnostics company and prior to that head of R&D for a global Neonatology and Paediatrics company. Over his career, he has delivered exceptional results in fast growing independent growth companies and corporate roles focused on increasing innovation, accelerating and sustaining growth. In addition to his corporate roles, he serves as an external independent expert reviewer on public sector life science investment programs and as a mentor and adviser to university technology transfer offices and innovation accelerators.

Country

City

Canada

Industry

Medical Device

Skill

Start-ups, Product Development, Strategy, Medical Devices, Commercialization, Process Improvement, R&D, Business Strategy, Manufacturing, FDA, Leadership, Entrepreneurship, Analysis, Biotechnology, Management, Operational Excellence, Cross-functional Team Leadership, Validation, Electronics, Quality Assurance

Experience

Chief Operating Officer

Cardiol Therapeutics Inc.

2020-12 - Present · 5 yrs 10 mos

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease.

Chair Of The Board Of Directors

Front Line Medical Technologies Inc.

2020 - Present · 6 yrs

Front Line Medical Technologies is a medical device company lowering the barriers to bleeding control and resuscitation worldwide. The company offers a life-saving tool, the COBRA-OS™ (Control of Bleeding, Resuscitation, Arterial Occlusion System) to help patients survive emergency situations including Trauma, Postpartum Hemorrhage (PPH) and Non Traumatic Cardiac Arrest (NTCA). The COBRA-OS is used for REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) procedures, and its significantly reduced size decreases both the time it takes to complete the procedure and the risk of complications.

Chair Of The Board Of Directors

Acuity Insights

2015 - Present · 11 yrs

Altus empowers higher education institutions to look beyond book smarts, and to identify and nurture exceptional professionals by using unique data to generate meaningful insights that influence key academic decisions. We do this through Altus Suite, made up of Casper, Snapshot, and Duet – assessments that provide a clearer, more holistic view of applicants. Our assessments are used by over 400 academic partners in the US, Canada, Australia (and growing!) with 200,000+ applicants taking our assessments each year, including 90% of Canadian and US medical school applicants.

Chair Of The Board Of Directors

AndersDX

2010-1 - Present · 16 yrs 9 mos

Anders specialises in the design, development & supply of world class interface and embedded technologies to our global B2B customers. We are the people behind your screens with operations in London, Amsterdam and Hong Kong.

Chair Of The Board Of Directors / Interim CEO

AndersDX

2015-1 - 2017-12 · 3 yrs

Member Board Of Directors

AndersDX

2008-12 - 2009-12 · 1 yr 1 mo

Executive-in-Residence

Innovation Factory

2012-12 - Present · 13 yrs 10 mos

As the resident Health and Life Sciences Executive-in-Residence for the Ontario Regional Innovation Centre, Bernard coaches and mentors the high potential start-ups, innovators, academic research spin-offs and external companies, accelerating them from research and development, funding through to commercialisation.

Board Director

AventaMed

2015 - 2023-1 · 8 yrs

Ireland

Aventamed innovates in ear-tube surgery enabling ENT procedures to be carried out in physician clinics instead of operating rooms. Excitingly acquired by Karl Storz in Jan 2023.

Managing Partner

JTL Global Ventures

2009 - 2020 · 11 yrs

Canada, US, UK, EU

Diagnostics - developed biomarker analysis strategy leading to equity funding Biotechnology - strategy development for an MBO Medical device - led expert witness testimony in IP / patent litigation Medical device - development and manufacturing strategy for a new product Specialized technology consumer product - new development approach for a breakthrough product platform